Ruth Ann Gillis
About Ruth Ann M. Gillis
Independent director of KeyCorp since 2009; age 70. Former EVP & Chief Administrative Officer of Exelon Corporation and President of Exelon Business Services Company; prior roles include Chief Diversity Officer and CFO at Exelon, CFO of the University of Chicago Hospitals and Health System, and senior management/lending roles at First Chicago (1977–1996). Designated “audit committee financial expert” and NACD Board Leadership Fellow since 2017; serves on Board of KeyBank National Association. Other public boards: Voya Financial (since 2015) and Snap‑on Incorporated (since 2014).
Past Roles
| Organization | Role | Tenure (as disclosed) | Committees/Impact |
|---|---|---|---|
| Exelon Corporation | EVP & Chief Administrative Officer; President, Exelon Business Services Company; Chief Diversity Officer; Chief Financial Officer | 2008–2014 | Senior executive roles in finance, operations, human capital, and regulatory in a Fortune 100 energy company |
| University of Chicago Hospitals and Health System | Chief Financial Officer | Not disclosed | Led financial management for major academic health system |
| First Chicago Corporation | Senior management and lending positions | 1977–1996 | Banking and credit leadership roles |
External Roles
| Organization | Role | Since | Notes |
|---|---|---|---|
| Voya Financial Inc. | Director | 2015 | Public company directorship |
| Snap‑on Incorporated | Director | 2014 | Public company directorship |
| KeyBank National Association | Director | Not disclosed | Subsidiary board of KeyCorp |
| Goodman Theatre | Life Trustee | Not disclosed | Non‑profit governance |
| Lyric Opera of Chicago | Life Director | Not disclosed | Non‑profit governance |
Board Governance
- Committee assignments: Audit Committee member; Audit met 14 times in 2024; Audit members are independent and financially literate; Gillis and the Chair (Hipple) are designated audit committee financial experts.
- Prior committee exposure: Previously served on Technology Committee until July 1, 2024, reflecting oversight of technology and cybersecurity topics.
- Independence: Board determined all directors other than the CEO (Gorman) are independent under NYSE and Key standards; independence reviewed annually against standards and related‑party policy.
- Engagement and attendance: Board held seven meetings in 2024; independent directors met in executive session at every regular meeting; average director attendance ~98%; no director attended fewer than 75%; all nominees attended the 2024 Annual Meeting.
- Board leadership: Independent Lead Director Alexander M. Cutler; standing committees consist solely of independent directors.
Fixed Compensation
| Item | 2024 Amount |
|---|---|
| Fees Earned or Paid in Cash (Gillis) | $115,000 |
| Stock Awards (grant date fair value) | $139,987 |
| Total 2024 Director Compensation (Gillis) | $254,987 |
Notes:
- Cash fees reflect base retainer plus Audit Committee member fee; footnotes list Gillis as an Audit Committee member in 2024.
- Director program structure (not individual): 2024 cash retainer $100,000 and deferred share award $140,000; 2025 cash retainer $105,000 and deferred share award $145,000. Additional retainers: Lead Director $45,000 (2024)/$50,000 (2025); Audit Chair $40,000; Audit/Risk member $15,000; extraordinary service retainer $15,000 (as applicable).
Performance Compensation
- Equity vehicle and vesting: Non‑employee directors receive annual awards of deferred shares (RSUs) under the Directors’ Deferred Share Sub‑Plan with a minimum three‑year deferral; on distribution, 50% in common shares and 50% in cash based on share value at the earlier of the end of deferral or separation; further deferral (optional) results in 100% share settlement. Awards are described as deferred shares (fully vested deferred RSUs), not performance‑conditioned.
Performance Metric Framework for Director Equity
| Element | Disclosure |
|---|---|
| Financial/TSR/ESG metrics | Not applicable—non‑employee director awards are deferred shares without performance conditions. |
| Deferral/settlement mechanics | 3‑year minimum deferral; 50% shares/50% cash on distribution; further deferral paid 100% in shares at elected date. |
Other Directorships & Interlocks
| Company | Role | Interlock/Conflict Notes |
|---|---|---|
| Voya Financial Inc. | Director (since 2015) | No interlocks with KeyCorp executives disclosed in Key’s proxy. |
| Snap‑on Incorporated | Director (since 2014) | No interlocks with KeyCorp executives disclosed in Key’s proxy. |
- Related‑party/ordinary course: The Board reviewed director relationships; transactions (including ordinary‑course banking/credit/wealth management) were on market terms, compliant with Regulation O, immaterial, and did not impair independence. No transactions exceeded 1% of consolidated gross revenue of either party in the last three fiscal years.
- Policy oversight: Related‑party transactions are governed by a formal Board policy administered by the Nominating & Corporate Governance Committee; ordinary‑course derivatives with Scotiabank (a significant holder) noted and monitored under Regulation O.
Expertise & Qualifications
- Extensive finance, banking, risk management, financial reporting, operations and technology, human capital, and regulatory expertise in complex, highly regulated industries.
- Audit Committee Financial Expert (SEC definition) and NACD Board Leadership Fellow (since 2017).
Equity Ownership
| Ownership Detail (as of March 21, 2025, unless noted) | Value |
|---|---|
| Common Shares (beneficially owned) | 174,024 |
| Options (exercisable within 60 days) | — (none reported) |
| Deferred Shares (distributable within 60 days) | — (none reported) |
| Other Deferred Shares Owned (not distributable within 60 days) | 58,270 |
| Total Beneficial Ownership | 174,024 |
| Combined Beneficial + Other Deferred Shares | 232,294 |
| Outstanding Stock Awards Payable in Common Shares (12/31/2024) | 57,518 |
Alignment policies and safeguards:
- Director/Officer stock ownership guidelines: Non‑employee directors must hold equity equal to at least 5× the annual cash retainer within five years and hold at least 1,000 directly‑owned shares.
- Hedging and pledging prohibitions: Directors, officers, and employees are prohibited from hedging and pledging KeyCorp securities; short sales and derivatives are also prohibited.
- Deferred share distribution mechanics and voting: Deferred shares are non‑voting until distributed; further deferrals are paid entirely in common shares at the elected date.
Governance Assessment
Strengths supporting investor confidence
- Deep financial, risk, and regulatory expertise; designated audit committee financial expert on a high‑activity Audit Committee (14 meetings in 2024).
- Independence affirmed; Board maintains independent committee structures and robust executive‑session cadence; strong attendance (avg. ~98%) and annual meeting participation.
- Director compensation balanced toward equity via deferred shares and multi‑year deferral, enhancing alignment; ownership guidelines plus strict hedging/pledging bans support “skin in the game.”
- Ongoing board refreshment (median tenure eight years; six new directors since 2020) with an independent Lead Director framework.
Watch‑items / potential red flags
- Tenure since 2009 indicates long service; while mitigated by active refreshment and independent oversight, some investors scrutinize extended tenure for independence perceptions.
- Director pay levels increased modestly for 2025 (base/deferred shares +$5,000 each; Lead Director +$5,000); still retainer‑based and largely equity‑aligned, but continued monitoring of pay inflation is prudent.
- No director‑specific related‑party issues disclosed; ordinary‑course banking/credit relationships and Scotiabank derivatives were on market terms and compliant—continue to monitor given large shareholder relationships.
Say‑on‑Pay context (broader governance signal)
- KeyCorp’s executive say‑on‑pay support averaged 92% over five years (90% in 2024), indicating generally strong shareholder alignment on compensation philosophy and oversight.